Trial Profile
A Study to Evaluate the Effect of Rituximab on T-Helper Cell (Th1/Th2/Th17) Balance in Patients with Primary Sjögren's Syndrome (pSS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Sjogren's syndrome
- Focus Pharmacodynamics
- 10 Dec 2015 New trial record